Source: Eur Respir Rev 2013; 22: 281-291
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Katerina M. Antoniou, George A. Margaritopoulos, Nikos M. Siafakas. Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future},. Eur Respir Rev 2013; 22: 281-291

Member's Comments

No comment yet.

Related content which might interest you: Chronic post-embolic pulmonary hypertension: a new target for medical therapies?}, Source: Eur Respir Rev 2013; 22: 258-264 Year: 2013 Does interferon-γ improve pulmonary function in idiopathic pulmonary fibrosis? Source: Eur Respir J 2003 Dec 01;22(6):906-911 Year: 2003 The therapy of idiopathic pulmonary fibrosis: what is next? Source: Eur Respir Rev, 28 (153) 190021; 10.1183/16000617.0021-2019 Year: 2019 Staging of idiopathic pulmonary fibrosis: past, present and future Source: Eur Respir Rev 2014; 23:220-224 Year: 2014 Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential Source: Eur Respir Rev, 26 (145) 170071; 10.1183/16000617.0071-2017 Year: 2017 PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery Source: Eur Respir Rev 2013; 22: 148-152 Year: 2013 Common pathways in idiopathic pulmonary fibrosis and cancer}, Source: Eur Respir Rev 2013; 22: 265-272 Year: 2013 Current and future therapeutic approaches in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: 693-703 Year: 2005 Targeted treatment of idiopathic pulmonary fibrosis: one step at a time Source: Eur Respir J 2016; 47:1321-1323 Year: 2016 Combination therapy in idiopathic pulmonary fibrosis: the way ahead will be hard Source: Eur Respir J 2015; 45: 1208-1210 Year: 2015 Treatment of pulmonary exacerbations in cystic fibrosis}, Source: Eur Respir Rev 2013; 22: 205-216 Year: 2013 The role of infection in the pathogenesis of idiopathic pulmonary fibrosis}, Source: Eur Respir Rev 2013; 22: 376-381 Year: 2013 Emerging potential treatments: new hope for idiopathic pulmonary fibrosis patients? Source: Eur Respir Rev 2011; 20: 201-207 Year: 2011 Idiopathic pulmonary fibrosis: present understanding and future options Source: Eur Respir Rev 2011; 20: 132-133 Year: 2011 Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation Source: Eur Respir J 2012; 40: 794-795 Year: 2012 A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials Source: Eur Respir J 2015; 46: 243-249 Year: 2015 Emerging anti-inflammatory strategies for COPD}, Source: Eur Respir J 2012; 40: 724-741 Year: 2012 Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence? Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Mechanisms of treatment response to pirfenidone of idiopathic pulmonary fibrosis (IPF) patients Source: International Congress 2016 – IPF pathogenesis Year: 2016